-+ 0.00%
-+ 0.00%
-+ 0.00%

This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday

Benzinga·06/08/2026 16:13:48
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • HC Wainwright & Co. analyst Robert Burns downgraded ADC Therapeutics SA (NYSE:ADCT) from Buy to Neutral. ADC Therapeutics shares closed at $1.0250 on Friday. See how other analysts view this stock.
  • Wells Fargo analyst Elyse Greenspan downgraded W. R. Berkley Corporation (NYSE:WRB) from Equal-Weight to Underweight and lowered the price target from $64 to $58. WR Berkley shares closed at $68.57 on Friday. See how other analysts view this stock.

Considering buying ADCT stock? Here’s what analysts think:

Photo via Shutterstock